Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Emil_D._Kakkis
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
rare diseases
|
| gptkbp:foundedBy |
gptkb:Emil_D._Kakkis
|
| gptkbp:foundedYear |
2010
|
| gptkbp:headquartersLocation |
gptkb:Novato,_California,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Crysvita
gptkb:Mepsevii |
| gptkbp:numberOfEmployees |
over 1000
|
| gptkbp:product |
gptkb:Crysvita
gptkb:Dojolvi gptkb:Evkeeza gptkb:Mepsevii |
| gptkbp:specializesIn |
development of novel products for rare and ultra-rare diseases
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
RARE
|
| gptkbp:tradedOn |
gptkb:NASDAQ:_RARE
|
| gptkbp:website |
https://www.ultragenyx.com/
|
| gptkbp:bfsParent |
gptkb:F-Prime_Capital
gptkb:F-Prime_Capital_Partners |
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ultragenyx
|